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Abstract
Background Vitamin A accumulates in renal failure, but the
prevalence of hypervitaminosis A in children with predialysis
chronic kidney disease (CKD) is not known. Hypervitamin-
osis A has been associated with hypercalcemia. In this study
we compared dietary vitamin A intake with serum retinoid
levels and their associations with hypercalcemia.
Methods We studied the relationship between vitamin A in-
take, serum retinoid levels, and serum calcium in 105 children
with CKD stages 2–5 on dialysis and posttransplant. Serum
retinoid measures included retinol (ROH), its active retinoic
acid (RA) metabolites [all-trans RA (at-RA) and 13-cis RA]
and carrier proteins [retinol-binding protein-4 (RBP4) and
transthyretin (TTR)]. Dietary vitamin A intake was assessed
using a food diary.
Results Twenty-five children were in CKD 2–3, 35 in CKD
4–5, 23 on dialysis and 22 posttransplant; 53 % had vitamin A
intake above the Reference Nutrient Intake (RNI) value. Chil-
dren receiving supplemental feeds compared with diet alone
had higher vitamin A intake (p=0.02) and higher serum ROH
(p<0.001). Notably, increased ROHwas seen as early as CKD
stage 2. For every 10 ml/min/1.73 m2 fall in estimated glo-
merular filtration rate (eGFR), there was a 13 % increase in
ROH. RBP4 levels were increased in CKD 3–5 and dialysis
patients. The lowest ratios of ROH:RBP4 were seen in dialy-
sis compared with CKD 2–3 (p=0.03), suggesting a relative
increase in circulating RBP4. Serum ROH, RBP4 and at-RA
were associated with serum calcium. On multivariable analy-
sis RBP4 levels and alfacalcidol dose were significant predic-
tors of serum calcium (model R2 32 %) in dialysis patients.
Conclusions Hypervitaminosis A is seen in early CKD, with
highest levels in children on supplemental feeds compared
with diet alone. Serum retinoid levels significantly predict
hypercalcemia.
Keywords VitaminA . Retinol . Retinol binding protein 4
(RBP4) . Hypercalcemia . Children
Introduction
The kidneys play an important role in the metabolism and
excretion of vitamin A [1, 2]. In healthy individuals, dietary
vitamin A is converted into retinol (ROH), stored in the liver
and transported by its carrier proteins—retinol-binding
protein-4 (RBP4) and transthyretin (TTR)—to its target cells
[1]. ROH is oxidized to its active form, retinoic acid (RA), and
free RBP4 (apo-RBP) is then degraded and filtered by the
kidneys [2]. Patients with impaired renal function have been
shown to have high circulating levels of ROH, possibly due to
a combination of decreased glomerular filtration of the ROH-
RBP4 complex, reduced conversion of ROH to RA [2], and an
accumulation of RBP4 [1, 3, 4] (Fig. 1). Studies in adults
[5–7] and children [8–10] on dialysis have shown increased
ROH and RBP4 levels. However, little is known about vita-
min A status at earlier stages of chronic kidney disease
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(CKD), its association with dietary intake, or the conse-
quences of high circulating vitamin A metabolites.
In the absence of evidence-based guidelines on vitamin A
intake in patients with CKD, accepted practice in the UK is to
avoid exceeding twice the Reference Nutrient Intake (RNI)
value [11]. The Kidney Disease Outcomes Quality Initiative
(KDOQI) guideline recommends that the total dietary vitamin
A intake should be limited to the Dietary Reference Intake
(DRI) value [12], the US equivalent to RNI value [13]. These
guidelines are opinion based, with no studies in the pediatric
CKD population to support them. This is difficult to achieve in
practice, since commercial nutritional supplements used in
CKD patients are fortified with vitamin A.
In our clinical practice, we have observed hypercalcemia in
some children with CKD even without the use of calcium or
vitamin D supplements, and hypothesized that vitamin A in
supplemental feeds was associated with hypercalcemia. In-
deed, case reports have suggested that high ROH levels are
associated with hypercalcemia, both in individuals with nor-
mal renal function [14, 15] and dialysis patients [16–18].
Also, retinoid levels have been linked to an increased risk of
subclinical cardiovascular disease in the general population
[19–21]. In animal models, pharmacological doses of vitamin
A suppress osteoblast activity [22] and increase osteoclast
formation and differentiation [23], which together manifest
as osteopenia, fractures, bony deformities, and growth arrest
and lead to a release of calcium from the bones. Hypercalce-
mia is a well-established risk factor for vascular calcification,
which, in turn, contributes to a high cardiovascular mortality
in adults and children with CKD [24–26]. In this study, we
compared dietary vitamin A intake with serum retinoid levels
and their associations with hypercalcemia.
Materials and methods
We recruited 105 consecutive children under 18 years of age
with CKD stages 2–5 [estimated glomerular filtration rate
(eGFR) < 90 ml/min/1.73 m2), on dialysis, or with a function-
ing renal transplant (≥ 3 months posttransplant) from nephrol-
ogy outpatient clinics at Great Ormond Street Hospital NHS
Foundation Trust (Table 1). Children with active liver disease
or receiving fat-soluble multivitamin supplements that can
influence vitamin A status were excluded. Informed written
consent from parents or caregivers, and assent from children
where appropriate, was obtained. The study was approved by
a local research ethics committee.
All clinical, anthropometric, and biochemical data were
collected at the time of a single outpatient visit. Doses of
phosphate binders and vitamin D supplements were noted
from clinic records, and calcium intake from phosphate
binders was calculated.
Biochemical analysis
Routine serum biochemistry including creatinine, calcium,
phosphate, parathyroid hormone (PTH) (Immulite 2500 Intact
PTH assay; Siemens), and 25-hydroxyvitamin D [(25(OH)D,
measured by isotope-dilution liquid chromatography–tandem
mass spectrometry (LC-MS)] were measured. Blood samples
for vitamin A metabolites ROH, carrier proteins RBP4, TTR,
and RA [all-trans RA (at-RA) and 13-cis RA] were frozen at
−80 °C and analyzed in batches. Serum ROHwas measured by
high-performance liquid chromatography (HPLC) with UV
detection in the Chemical Pathology Laboratory at Great
Ormond Street Hospital. RBP4 and TTR were measured by
nephelometry (Siemens BN2 nephelometer) at the Sheffield
Protein Reference Unit, UK. Serum 13-cis-RA and at-RAwere
measured in 53 randomly selected children (CKD 2–3 n=13,
CKD 4–5 n=20, dialysis n=5, transplant n=15) by LC-MS at
Vitas, Oslo Innovation Centre, Norway [27]. The molar ratios
of ROH:RBP4 and RBP4:TTR were calculated. Patients were
compared with 12 healthy age- and gender-matched children
attending ear nose and throat (ENT) clinics at our hospital.
Normal levels of ROH are well established and are age specific,
as outlined in Table 2. RBP4 and TTR levels were measured
(Table 2). Only adult reference ranges for at-RAwere available
at the time of the study and are 0.9–2.0 ng/ml.
Dietary analysis
A food diary and details of supplementary feeds were requested
for 3 nonconsecutive days. Completed food diaries were ob-
tained for 72 (69 %) children. Children were divided into three
groups based on the level of nutritional support they consis-
tently received: feed only, diet and supplementary feed, or
diet alone. Feed products used were standard infant, infant–
pediatric, or adult-renal-specific feeds. Feeds were adjusted to
control biochemistry and meet full nutritional requirements; it
is not possible to titrate feeds based upon recommended vita-
min A intakes alone. Feeds were given either orally or via a
nasogastric or gastrostomy tube. Patients on diet alone were
advised on protein, phosphate, and potassium intakes, as ap-
propriate, for their CKD stage as per KDOQI guidelines [12].
The intake of food from food diaries was expressed in grams
or milliliters (taken from original food labels where appropri-
ate). Software packages COMPEAT (Nutrition Systems,
Banbury, UK) and Electronic Dietetics Manager (edm2000,
Milton Keynes, UK) were used for analyses of dietary vitamin
A intake from diet and supplemental feeds. Dietary ROH
equivalents included provitamin A carotenoids from plant
sources and retinyl esters from animal sources and were col-
lectively grouped and expressed as the equivalent mass of
retinol. Dietary vitamin A intake was also expressed as a
percentage of RNI (defined as the amount of a nutrient that is
sufficient to meet the nutritional needs of 97.5 % of a
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population of healthy individuals) [13]. The RNI for vitamin A
is age and gender specific, as follows: 350 μg (0–12 months),
400μg (1–6 years), 500μg (7–10 years), 600μg (11–14 years),
600 μg (15–18 years in females), and 700 μg (15–18 years in
males). The USA Institute of DRI is similar [28]: 300 µg (1–
3 years), 400 μg (4–8 years), 600 μg (9–13 years), and 750 μg
(14–18 years). Dietary vitamin D, calcium, and phosphate were
also calculated from the food diaries. All dietary calculations
were performed by a single experienced renal dietician who
was blinded to patients’ CKD status.
Statistical analysis
Data were analyzed using SPSS, version 19 (SPSS, Chicago,
IL, USA). As most variables had non-normal distributions,
data were expressed as medians and interquartile ranges
(IQR). Tests for difference in medians between groups were
performed by Wilcoxon rank-sum test. Simple linear regres-
sion was used to test for associations between serum concen-
trations of ROH and its metabolites and ROH with eGFR;
logarithms of concentrations were used to capture the nature
of the relationship. Simple linear regression was used to
investigate associations between serum albumin-adjusted cal-
cium concentration and candidate predictors. Variables with
p values < 0.15 were included in a stepwise multiple linear
regression analysis. P<0.05 was taken to be statistically
significant.
Results
Clinical and biochemical characteristics of the 105 patients,
stratified by CKD stage, are described in Table 1. Children in
CKD 2–3 were younger and transplant recipients older. There
was a higher proportion of glomerular disease in the dialysis
group. Calcium, phosphate, and PTH levels, and use of phos-
phate binder and activated vitamin D were highest in dialysis
patients.
Vitamin A intake
Data on vitamin A intake was available in 72 children (69 %):
14 (19 %) were dependent on feeds alone, 29 (40 %) received
a combination of diet and supplementary feed, and 29 (40 %)
were on diet alone. Children receiving exclusive or supple-
mentary feeds had a higher vitamin A intake compared with
those on diet alone (119 % vs. 104 % vs. 71 % of RNI,
respectively, p=0.02) (Fig. 2a); 53 % of children exceeded
the age-specific RNI for vitamin A intake, with 6% exceeding
twice the RNI; 38 % of children on diet alone exceeded the
RNI; 62 % on supplementary feeds and 64 % on feeds alone
exceeded the RNI. There was no significant difference in
vitamin A intake between CKD groups (p=0.45) (Table 2).
Of note, none of the patients received medications containing
vitamin A.
Circulating levels of vitamin A metabolites
In 77 % of children, serum ROH levels were above the upper
limit of normal (ULN) for age. A higher dietary vitamin A
intake relative to RNI was directly associated with a higher
serum ROH level (p<0.001) (Fig. 2b). Higher serum ROH
was seen in children on feed alone [3.1 (2.3–5.3) μmol/l], and
those on supplementary feed and diet [2.8 (2.3–3.4) μmol/l]
compared with those on diet alone [2.5 (1.8–3.3) μmol/l]
(p<0.001 between groups). Importantly, dialysis patients were
more likely to have higher ROH levels relative to their vitamin
Fig. 1 Metabolism, transport,
and degradation of vitamin A
under physiological conditions.
RBP retinol binding protein,
ROH retinol, TTR transthyretin
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A intake: when the vitamin A intake was < 50% of RNI, 22%
of children on dialysis had increased ROH, whereas only 7 %
of children in CKD 2–5 had increased ROH at similar RNI.
There was a significant negative association between se-
rum ROH and eGFR in nontransplant patients (p<0.001, R2=
0.34) (Fig. 3a). For every 10 ml/min/1.73 m2 fall in eGFR,
there was a 13 % rise in serum ROH, even after correcting for
vitamin A intake. A similar but weaker association was seen in
transplant recipients (p=0.03, R2=0.2; data not shown).
Levels of at-RA were below the normal range for all
patients, with lowest levels in CKD 2–3 and higher levels in
dialysis patients. There was an inverse linear association be-
tween at-RA and eGFR (p=0.001, R2=0.21) (Fig. 3b).
Among the transplant group, where the median eGFR was
63 ml/min/1.73 m2, at-RA levels were comparable with those
seen in CKD 2–3 patients [0.46 (0.4–0.58) vs 0.48 (0.4–0.49)
ng/ml; p=0.17]. No correlation was observed between eGFR
and 13-cis RA (p=0.6). Children in CKD stages 3–5 and on
dialysis had high levels of RBP4 (Fig. 3c). Both RBP4 and
TTR levels increased with declining GFR (p<0.0001, R2=
0.40; p<0.001, R2=0.32, respectively) and were highest in
dialysis patients. Although there was a linear association
between serum ROH and RBP4 (p<0.001, R2=0.76), molar
ratios for ROH:RBP4 showed a significantly different binding
pattern at different CKD stages (Table 2), with the lowest
ratios in CKD 4–5 and dialysis groups (0.72 and 0.59, respec-
tively) compared with CKD 2–3 patients (0.81; p=0.03);,sug-
gesting relatively higher amounts of free RBP4 (apo-RBP)
with advanced CKD. Similarly, an increased RBP4:TTR ratio
was seen, suggesting increased amounts of non-TTR-bound
RBP4 in dialysis compared with CKD 2–3 patients (1.44 vs.
0.82; p=0.02) (Table 2).
Serum levels of ROH, RBP4, TTR, and RA were not
influenced by dialysis modality or duration (data not shown).
RBP4 is an adipokine, and elevated RBP4 levels are associ-
ated with obesity; however, in our cohort, there was no asso-
ciation between body mass index (BMI), expressed as stan-
dard deviation score (SDS) and RBP4 levels or any other
serum retinoid levels. RBP4 levels were associated with total
cholesterol in transplant recipients (p=0.05, r=0.2). No pa-
tient had clinical signs or symptoms of vitamin A toxicity,
such as alopecia, pruritus, or raised intracranial pressure.
Associations with serum albumin-adjusted calcium
A higher vitamin A intake was associated with higher calcium
levels (p=0.03, R2=0.16): for each 10 μg/kg/ per day increase
in vitamin A intake, there was a 0.03 mmol/l increase in
albumin-adjusted calcium levels (Fig. 4). Notably, there was
no association between dietary vitamin A intake and dietary
vitamin D or calcium intakes. The total calcium intake (from
diet and binders) increased with CKD stage, but only four
children (one CKD 5 and three on dialysis) exceeded the RNI
for calcium from diet and binders combined (Table 1).
Children with higher ROH levels had significantly higher
albumin-adjusted calcium levels (p=0.004; R2=12) (Fig. 5a).
Similarly, there was a positive association between at-RA and
albumin-adjusted calcium (p=0.002, R2=0.16) (Fig. 5b) and
RBP4 and albumin-adjusted calcium (p<0.0001, R2=0.15)
(Fig. 5c). No association was seen with 13-cis RA. Dialysis
patients with the highest Alkaline phosphatase (ALK) had the
lowest RBP4 levels (p=0.04, r=0.22).
Potential predictors of serum albumin-adjusted calcium
levels [eGFR, calcium intake (from diet and binders
Table 2 Dietary vitamin A intake and serum levels
Normal reference range CKD 2–3
(n=25)
CKD 4–5
(n=35)
Dialysis
(n=23)
Transplant
(n=22)
P value
Vitamin A intake data
available [n (%)[
19 (76 %) 25 (71 %) 21 (91 %) 7 (32 %)
Vitamin A intake (µg/day) 486 (422–795) 418 (329–509) 440 (315–579) 459 (382–649) 0.45
Serum ROH (µmol/l) 1–6 years 0.7–1.5; 6–12 years
0.9–1.7; 12–19 years 0.9–2.5
2.26 (1.72–2.57) 3.21 (2.37–3.77) 3.79 (3.09–5.32) 1.99 (1.65–2.48) <0.001
13 cis-RA (ng/ml) (n=53) 0.9–2.0a 0.46 (0.36–0.61) 0.47 (0.34–0.52) 0.45 (0.4–0.45) 0.41 (0.32–0.49) 0.41
at-RA (ng/ml) (n=53) 0.9–2.0a 0.46 (0.4–0.58) 0.56 (0.46–0.68) 0.65 (0.64–0.74) 0.48 (0.4–0.49) <0.001
Serum RBP4 (µmol/l) 0.94–2.41 2.83 (2.17–3.57) 4.67 (4.00–5.40) 6.84 (6.42–8.61) 2.15 (1.76–2.98) <0.001
Serum TTR (µmol/l) 1.93–5.22 3.38 (2.92–3.69) 4.62 (4.15–5.38) 4.92 (4.31–5.54) 3.46 (3.00–3.85) <0.001
ROH:RBP4 0.81 (0.71–0.88) 0.72 (0.56–0.82) 0.59 (0.41–0.73) 0.92 (0.79–1.00) 0.03
RBP4:TTR 0.82 (0.82–0.94) 1.00 (0.89–1.13) 1.44 (1.35–1.72) 0.70 (0.56–0.83) 0.02
Data are expressed as median (interquartile range) P values are for comparison across all groups obtained from one-way analysis of variance (ANOVA)
or Kruskal–Wallis test, as appropriate
CKD chronic kidney disease, ROH retinol, 13 cis-RA 13-cis Retinoic acid, at-RA all-trans retinoic acid, TTR transthyretin
a Adult reference ranges for at-RA
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combined), alfacalcidol dose, serum levels of 25-
hydroxyvitamin D, vitamin A intake, serum ROH, RBP4,
and all-trans RA] were tested. On univariate analysis, there
were no significant predictors for calcium levels in the CKD
2–5 or transplant cohorts (and no patient had p values < 0.15
for inclusion in a multivariable model). However, among
children on dialysis, vitamin A intake (p=0.02, R2=0.14),
alfacalcidol dose (p=0.0003, R2=0.32), and RBP4 levels
(p=0.008, R2=0.26) were significantly associated with
albumin-adjusted calcium. On stepwise linear regression anal-
ysis, only alfacalcidol dose and RBP4 levels were significant-
ly associated with albumin-adjusted calcium levels (p<0.004,
β=0.22 and p=0.01, β=0.11; model R2=32 %).
Discussion
In this study, we examined children across a wide range of
kidney function and found that hypervitaminosis A is seen
even in early CKD and may be attributed to an increased
vitamin A intake, particularly through supplementary feeds.
High levels of RBP4 were significantly and independently
associated with hypercalcemia in dialysis patients. Accumu-
lation of RBP4, as evidenced by an altered molar ratio of
ROH:RBP4, may be the stimulus that triggers further hepatic
release of ROH [1, 2].
Fig. 3 Association of serum retinoid levels with chronic kidney disease
(CKD) stages and estimated glomerular filtration rate (eGFR). a Serum
retinol levels, b serum all-trans retinoic acid levels, c serum retinol-
binding protein-4 levels. Dotted lines represent normal range
Fig. 2 a Vitamin A intake is higher in children on supplemental feeds or
feeds alone comparedwith those on a diet. The dietary vitamin A intake is
expressed as multiples of the age-specific Reference Nutrient Intake
(RNI). b Serum retinol levels (expressed as multiples of the age-specific
upper limit of normal) were highest in children on supplemental feeds or
feeds alone compared with those on a diet alone. The hyphen represents
the median in each category
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Previous studies in both adults [5–7] and children [8–10]
focused on dialysis patients only and showmarked increase in
serum ROH and RBP4 levels. Pediatric studies show that
ROH levels are between two- and fivefold higher than normal
in children on dialysis and stress the importance of avoiding
vitamin A supplementation in these patients [10, 29]. In the
largest study, by Fassinger et al., increased levels of ROH,
RBP4, and TTR were reported in all children on dialysis, with
results comparable with adult dialysis patients [8]. Converse-
ly, Zwolińska et al. showed low vitamin A levels in children
on hemodialysis (HD) [30]. There are no studies reporting on
children in predialysis CKD. In this study, we show increased
levels of ROH, at-RA, RBP4, and TTR, even in CKD 2
patients, with a strong inverse association with eGFR: for
each 10 ml/min/1.73 m2 fall in eGFR, there was a 13 % rise
in serum ROH. Notably, none of the children in our study
received medications containing vitamin A. A previous study
implied a similar finding of hypervitaminosis A even with
mildly reduced renal function: in kidney donors, even a mod-
est reduction in renal function was associated with increased
ROH, RBP4, and TTR levels [31].
Despite a linear increase in ROH and its carrier proteins
RBP4 and TTR with declining eGFR, we found altered bind-
ing properties of ROH to RBP4 at different CKD stages. The
molar ratio of ROH:RBP4 was significantly reduced in CKD
4–5 and dialysis patients compared with CKD 2–3 or trans-
plant recipients, suggesting increased circulating levels of
RBP4. In CKD patients, we found that RBP4 levels were
substantially increased compared with those of TTR; this is
in keeping with previous studies that show increasing serum
RBP with declining GFR [32]. Under physiological condi-
tions, the ROH:RBP4 complex has high affinity to TTR, thus
protecting RBP from glomerular filtration and renal catabo-
lism [33] (Fig. 1). After releasing ROH into target cells, apo-
RBP (RBP without ROH) is filtered through glomeruli and
reabsorbed via the megalin–cubilin receptor complex and
catabolized [34]. This observation supports an earlier hypoth-
esis that apo-RBP provides a positive feedback signal for
hepatic release of the ROH–RBP4 complex [35, 36], leading
to a vicious cycle of increased circulating RBP4. In postmen-
opausal women, increased RBP4 levels have been associated
with coronary artery calcification [18]. High ROH and RBP4
serum concentrations have been linked to an increased intima-
media thickness, an established surrogate marker for cardio-
vascular disease [17].
We found that at-RA levels were below the normal range in
all CKD patients, suggesting a reduced conversion of ROH to
at-RA in CKD, as previously described [1, 2]. Paradoxically,
the lowest levels of at-RA were seen in CKD 2–3 and trans-
plant recipients, whereas highest levels were found in dialysis
patients. at-RA has not been previously described in CKD
patients, and these findings need to be explored in larger
patient cohorts. Also, it is not clear why at-RA levels below
the normal range are associated with hypercalcemia.
Importantly, vitamin A is not simply one more uremic
retention product but has been linked with abnormal osteo-
clast function and hypercalcemia. Even in individuals with
normal renal function, administration of supplements contain-
ing vitamin A has been linked with hypercalcemia [37–39].
Receptors for RA are located on both osteoblasts and osteo-
clasts, indicating that they are direct vitamin A targets [40]. In
animal studies, elevated RA can increase serum calcium by
suppressing osteoblast activity, stimulating osteoclast
Fig. 4 Increased vitamin A intake is associated with serum albumin-
adjusted calcium levels
Fig. 5 Association of serum retinoid levels with albumin-adjusted calcium levels. a Serum retinol levels, b serum all-trans retinoic acid levels, c serum
retinol-binding protein-4 levels
Pediatr Nephrol
formation [22] and differentiation from their postmitotic pre-
cursors [23] and reducing osteoid formation [41]. Interesting-
ly, these changes were most marked in the growing skeleton
[41]. In a study in postmenopausal women, a weak association
between vitamin A intake and fracture risk has been observed
[37]. Hypercalcemia can also promote or exacerbate ectopic
vascular calcification that is part of CKD–mineral and bone
disorder (CKD-MBD) complex. Mice fed a diet high in vita-
min A developed aortic valve calcification, with an upregula-
tion of osteogenic genes within the aortic valve leaflets [42].
In previous studies, increased RBP4 levels were associated
with coronary artery calcification [20], and increased ROH
and RBP4 are linked to an increased intima-media thickness
[19]. We found a significant correlation between serum ROH,
RBP4, and at-RA levels with albumin-adjusted calcium. Giv-
en that there was a very low prevalence of hypercalcemia in
our patients, this suggests that vitamin A metabolites may
influence serum calcium levels even within the normal range.
Also, in patients with unexplained hypercalcemia, particularly
those with impaired renal function, vitamin A toxicity should
be considered.
We found that dietary vitamin A intake was associated with
increased levels of ROH and increased serum calcium levels
on univariate analysis, although this lost its significance on
multivariate analysis. Previous studies in adults [16, 18] and
children [10, 29] show elevated serum ROH in dialysis pa-
tients and prompted recommendations to restrict vitamin A
supplements. Of note, none of our patients were on vitamin A
supplements, but high ROH levels were in seen in 53 % of
children and were present from earlier stages of CKD. Nota-
bly, 87 % of children in CKD 2–5 and on dialysis had
increased ROH levels, even though their vitamin A intake
was below the RNI. These data suggest that current recom-
mendations for dietary vitamin A intake in children with
CKD, both from KDOQI [12] and UK practice [11], may be
too high.
For children with CKD, particularly those < 2 years of age,
standard infant or pediatric formulas are often used, either
alone or as supplementary feeds. The level of vitamin A
fortification in standard feeds, as well as renal-specific feeds,
may be too high for children with CKD. Currently available
feeds can provide up to twice the RNI for vitamin A, and it is a
challenge to reduce intake to the RNI without compromising
overall protein and energy intake. Although acceptable vita-
min A intake is not known, our data suggest intake below the
current RNI may be safe. In two cohorts of healthy breastfed
infants [43–45] in whom vitamin A intake was 100 μg/day
(29 % of RNI), there were no signs of vitamin A deficiency.
Intakes lower than the RNI maintained satisfactory ROH
concentrations in healthy preschool children [45].
There are some important limitations of this single-center,
cross-sectional study. We were unable to distinguish between
sources of dietary vitamin A; retinol absorption from plant and
animal sources is highly variable. Given the important asso-
ciations with RBP4 and hypercalcemia, it would have been
useful to measure apo-RBP4 and free ROH. Previous studies
show that RBP4 levels are correlated with indices of insulin
resistance, which would be interesting to assess in future
studies. Finally, we were unable to study the effects of hyper-
calcemia on cardiovascular structure or function.
In summary, we show that hypervitaminosis A is present
from early stages of CKD in children and is associated with
increased dietary vitamin A intake, particularly from supple-
mentary feeds. RBP4 levels are significantly and independent-
ly associated with hypercalcemia in patients on dialysis. A
multicenter study in children across all CKD stages is required
in order to determine safe vitamin A intake levels.
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